On Thursday, April 2nd, RheumNow hosted its' first Town Hall Meeting for Rheumatologist, with this 90 minute discussion devoted to the COVID-19 crisis as it affects Rheumatologists. 

Dr. Jack Cush reviews the news on COVID-19 and FDA actions this past week. Be sure to check out:

In early March 2020, there were widespread recommendations that wearing routine "surgical masks" by the public sector was not likely to be helpful or advisable. Now we are hearing of a 180 degree shift in thinking with the CDC, leading health officials and the current NEJM Perspective pointing to more widespread use of masks by healthcare workers and even by individuals in the public sector.

The March 31 release of the Morbidity and Mortality Weekly Report (MMWR) reviews the impact of several key comorbidities, most commonly diabetes mellitus, chronic lung disease, and cardiovascular disease, as cofactors leading to worse outcomes with COVID-19 infections.  Below are e

Dr. Jack Cush reviews the news and COVID developments from this past week.

The American College of Rheumatology (ACR) has published a guidance document on infusions and office based therapies.

In the midst of a global pandemic of the 2019 Novel coronavirus acute respiratory disease (COVID-19), a small handful of Rheumatologists gathered on social media to collectively grapple with the impact of this virus on vulnerable populations with rheumatic disease.

With the COVID-19 pandemic dynamically changing, we have provided several news items germane to the Rheumatologist.

As the highly virulent SARS-CoV-2 spreads over the world, uncertainty and fear for our patients with rheumatic diseases mount.  

We are in the early stages of trying to limit the morbid and mortal consequences of the corona virus pandemic of 2020. Not surprisingly, the recommendations designed to limit exposure and damage continually highlight the fact that the elderly and immunosuppressed may be amongst the most severely affected should they become infected with this virus.

This has led to a great deal of uncertainty by patients and providers about how rheumatic diseases and their treatments need to be specifically addressed.

Risks of infection were strikingly high among patients with antineutrophil cytoplasmic antibody-associated (ANCA) vasculitis, which may relate to both the disease and its treatment, Scottish researchers found.

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

Dr Jack Cush Reviews the news and journal articles from the past week on RheumNow.com

Dr Jack Cush reviews the news and journal articles from the past week on RheumNow.com

Shingles infection has been historically linked to an increased risk of stroke. A new study found that Zoster Vaccine Live, one type of shingles vaccination, may prevent stroke in some older adults.

Dr Jack Cush reviews the news and journal articles from the past week on RheumNow.com

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

Dr Jack Cush comments on this week's journal articles, reviews and studies.